Literature DB >> 7391895

Large bilateral medial rectus recession in early esotropia with bilateral limitation of abduction.

J Prieto-Diaz.   

Abstract

Large bilateral medial rectus recession was performed in a group of 85 patients presenting early large angle esotropia with bilateral limitation of abduction. The results obtained after three postoperative years demonstrated that the proposed method not only corrects the angle of deviation but significantly improves abduction and consequently torticollis. In spite of the large recession performed, both adduction and convergence were not significantly affected.

Entities:  

Mesh:

Year:  1980        PMID: 7391895     DOI: 10.3928/0191-3913-19800301-09

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  6 in total

1.  Augmented medial rectus recession in the management of esotropia.

Authors:  H E Willshaw; N Mashhoudi; S Powell
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

2.  Surgical management of large angle congenital esotropia.

Authors:  L B Nelson; J H Calhoun; J W Simon; T Wilson; R D Harley
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

3.  8 mm bimedial rectus recession in infantile esotropia of 80-90 prism dioptres.

Authors:  A G Damanakis; P G Arvanitis; I D Ladas; G P Theodossiadis
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

4.  Large bimedial rectus recessions in congenital esotropia.

Authors:  S M Szmyd; L B Nelson; J H Calhoun; C Spratt
Journal:  Br J Ophthalmol       Date:  1985-04       Impact factor: 4.638

5.  Comparative study of Y-split recession versus bilateral medial rectus recession for surgical management of infantile esotropia.

Authors:  Nermeen Badawi; Khaled Hegazy
Journal:  Clin Ophthalmol       Date:  2014-05-23

6.  Essential infantile esotropia: postoperative motor outcomes and inferential analysis of strabismus surgery.

Authors:  Adriano Magli; Roberta Carelli; Francesco Matarazzo; Dario Bruzzese
Journal:  BMC Ophthalmol       Date:  2014-03-25       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.